Buradasınız

Atopik Dermatit

Atopic dermatitis

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Atopic dermatitis is a recurrent, chronic, inflammatory dermatose that begins in infancy and early childhood. İt is a itching and eczamatous disorder and its' incidence is progressively increasing in recent years. Although etiology of atopic dermatitis is not completely understood, it is considered that a complex, multifactorial etiology plays a role in this disease. İn this review, pathogenesis, clinical features, diagnosis and treatment modalities of atopic dermatitis were presented.
Abstract (Original Language): 
Atopik dermatit çoğunlukla infant ve erken çocukluk çağında başlayan, tekrarlayıcı, kronik, inflamatuvar bir deri hastalığıdır. Kaşıntılı ve ekzematöz bir hastalık olan AD'in son yıllarda görülme sıklığı giderek artmaktadır. Hastalığın etyolojisi tam olarak bilinmemekle beraber kompleks multifaktöriyel bir etyolojinin roloynadığı düşünülmektedir. Bu yazıda AD'in patogenezi, kliniği, tanı ve tedavi yöntemleri sunulmaktadır.
21-25

REFERENCES

References: 

1. Leung
DY,Thar
p M, Boguniewicz M. Atopic dermatitis. In:Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg IM, Austen KF. Fitzpatrick's Dermatology In General Medicine 5th ed Newyork, Mc Graw Hill, 1999;1464-80.
2. Brehler RB, Luger TA. Atopic dermatitis: The role of pity-rosporum ovale. J Eur Acad Dermatol Venereol. 2001;15(1):5-6.
3. Kristal L. Atopic dermatitis in infants and children. An
update. Pediatr Clin North Am. 2000;47(4):877-95.
4. Hanifin JM, Chan S. Biochemical and immunologic mech¬anisms in atopic dermatitis: new targets for emerging ther¬apies. J Am Acad Dermatol. 1999;41(1):72-7.
5. Meagher LJ, Wines NY, Cooper AJ. Atopic dermatitis: review of immunopathogenesis and advances in immuno-suppressive therapy.
Australas J Dermatol. 2002;43(4):247-54.
6. Uehara M, Kimura C. Descendant family history of atopic dermatitis. Acta Derm Venereol. 1993;73(1):62-3.
7. Jaffe R. Atopic dermatitis . Primary Care. 2000;27(2):503-
13.
8. Thestrup-Pedersen K. Atopic dermatitis: summary of the 1st Georg Rajka symposium 1998 and a literature review.
S.D.Ü. Tıp Fak. Derg. 2004;11(2):21-25
Yıldırım,
Atopi
k Dermatit
25
Acta Derm Venereol. 1999; 79(4): 257-64.
9. Diepgen TL. Atopic dermatitis: The role of environmental and social factors the European experience. J Am Acad
Dermatol. 2001;45(1 Suppl):S44-8.
10. Olesen BA. Role of the early environment for expression of atopic dermatitis. J Am Acad Dermatol. 2001;45(1 Suppl):S37-40.
11. Lugovic L, Lipozenocic J, Jakic-Razumovic J. Atopic der¬matitis: immunophenotyping of inflammatory cells in skin
lesions. Int J Dermatol. 2001.40:489-94.
12. Aksungur V. Atopik Dermatit. In: Oğuz O, Serdaroğlu S.
Dermatolojide Gelişmeler 3. İstanbul, 1998;87-100.
13.
Gülmezoğl
u E, Ergüven S. Lenfoid hücrelerin bireysel gelişmesi. İmmunoloji 1. Baskı Ankara, Feryal Matbaası, 1994;119-116.
14. Watanabe K, Kondo N, Fukutomi O. Characterization of infiltrating CD4+cells in atopic dermatitis CD45R and CD29 monoclonal antibodies. Ann Allergy. 1994;
72(1):39-44
15. Eedy DJ. What's new in atopic dermatitis? Br J Dermatol. 2001;145(3): 380-4.
16. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 1999;104(3 Pt 2):S99-108.
17. Hamid Q, Boguniewicz M, Leung D. Differential in situ cytokine gene expression in acute versus chronic atopic der¬matitis. J Clin Invest. 1994;94(2):870-6.
18. Halbert AR, Weston WL, Morelli JG. Atopic dermatitis: is it an allergic disease?
J Am Acad Dermatol. 1995;33(6):1008-18.
19. Banfield CC, Callard RE, Harper JI. The role of cuta¬neous dendritic cells in the immunopathogenesis of atopic dermatitis. Br J Dermatol. 2001;144(5):940-6.
20. Stingl G. IgE-mediated, Fc(epsilon)RI-dependent allergen presentation: a pathogenetic factor in atopic dermatitis? J Am Acad Dermatol. 2001;45(1 Suppl):S17-20.
21. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B. Epidemiology, clinical features, and immunol¬ogy of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy. 2001;56(9):841-9.
22. Reitamo S. Tacrolimus : A new topical immunomodulato-ry therapy for atopic dermatitis. J Allergy Clin Immunol. 2001;107(3):445-8.
23. Imokawa G. Lipid abnormalities in atopic dermatitis. J
Am Acad Dermatol. 2001;45(1 Suppl):S29-32.
24. Horrobin DF. Essential fatty acid metabolism and its mod¬ification in atopic eczema. Am J Clin Nutr. 2000;71(1
Suppl):367S-72S.
25. Soyland E, Funk J, Rajka G, Sandberg M, Thune P, Rustad L, Helland S, Middelfart K, Odu S. Dietary supple¬mentation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol. 1994;130(6):757-64.
26. Ruzicka T. Atopic eczema between rationality and irra¬tionality. Atopic eczema between rationality and irrational¬ity. Arch Dermatol. 1998;134(11):1462-9.
27. Savaşkan H. Atopik dermatit. In: Tüzün Y, Kotoğyan A, Aydemir EH, Baransü O. Dermatoloji 1. Baskı İstanbul,
Cem Ofset Matbaacılık, 1994;257-265.
28. Baykal C. Atopik dermatit. Dermatoloji Atlası 1. Baskı
ARGOS
İletişi
m Hizmetleri 2000;189-92.
29. Odom RB, James WD, Berger TG. Atopic dermatitis, eczema, and non infectionus immuno deficiency disorders. Andrews' disease of the skin 9th ed Philadelphia, W.B. Saunders Company, 2000;69-76.
30. Thestrup-Pedersen K. Clinical aspects of atopic dermati¬tis. Clin Exp Dermatol. 2000;25(7):535-43
31. Aksungur VL. Atopik dermatit. In: Aksungur VL, Acar MA. Deri sorunlarında basamak basamak tanı ve öneriler 1. Baskı Adana, 5G Matbaacılık, 1999;186-8.
32. Hanifin JM, Tofte SJ. Update on therapy of atopic der¬matitis. J Allergy Clin Immunol. 1999;104(3 Pt 2):S123-5.
33. Correale CE, Walker C, Murphy L, Craig TJ. Atopic der¬matitis: A review of diagnosis and treatment. Am Fam Physician. 1999;60(4):1191-8, 1209-10.
34. Stephens RB, Cooper A. The caseload, assessment and treatment of atopic dermatitis: a survey of Australian der¬matologists. Australas J Dermatol. 1999;40(4):187-9.
35. İçke İ, Başak PY. Atopik dermatitte tedavi yaklaşımları: Sistemik inceleme. T Klin J Allergy- Asthma 2002;4:149-56.
36. Kimata H, Hiratsuka S. Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodi¬um cromoglycate solution with the oral anti-allergic med¬ication, oxatomide. Eur J Pediatr. 1994;153(2):66-71.
37. Sidbury R, Hanifin JM. Old, new, and emerging therapies for atopic dermatitis. Dermatol Clin. 2000;18(1):1-11.
38. Dicarlo JB, McCall CO. Pharmacologic alternatives for severe atopic dermatitis. Int J Dermatol. 2001
Feb;40(2):82-8.
39. Hannuksela M, Kalimo K, Lammintausta K, Mattila T, Turjanmaa K, Varjonen E, Coulie PJ. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann
Allergy. 1993;70(2):127-33.
40. Veien NK, Kaaber K, Larsen PO, Nielsen AO, Thestrup-Pedersen K. Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial. J Am Acad Dermatol. 1995;32(6):1056-7.
41. Lear JT, English JS, Jones P, Smith AG. Retrospective review of the use of azathioprine in severe atopic dermati¬tis. J Am Acad Dermatol. 1996;35(4):642-3
42. Sidbury R, Hanifin JM. Systemic therapy of atopic der¬matitis.
Clin Exp Dermatol. 2000;25(7):559-66.
43. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol. 2001 Jul;137(7):870-3.
44. Yanase DJ, David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol. 2001;44(1):89-93.
45. Leroy BP, Boden G, Lachapelle JM, Jacquemin MG, Saint-Remy JM. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-con¬trolled study. J Am Acad Dermatol. 1993;28(2 Pt 1):232-9.

Thank you for copying data from http://www.arastirmax.com